Our findings that NSCLC patients have high frequencies of RARβ gene promoter methylation compared to the normal lung tissues, indicating that the detection of RARβ hypermethylation may provide a practical diagnostic marker for NSCLC patients. The gene discussed is RARB; the disease is non-small cell lung carcinoma.